EPISODE · Jun 19, 2026 · 17 MIN
Updates on Metabolic Dysfunction-Associated Steatohepatitis Treatment
from Keeping Current CME
Two FDA-approved MASH therapies are changing care. Learn how resmetirom and semaglutide work—and what's next in the pipeline. Credit available for this activity expires: 6/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/updates-metabolic-dysfunction-associated-steatohepatitis-2026a1000jmw?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Updates on Metabolic Dysfunction-Associated Steatohepatitis Treatment
0:00
17:06
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 17 minutes long.
When was this Keeping Current CME episode published?
This episode was published on June 19, 2026.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!